Daré Bioscience, Inc. (DARE) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Daré Bioscience, Inc. (DARE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $22.2M, listed on NASDAQ, employing roughly 21 people, carrying a beta of 1.09 to the broader market. Daré Bioscience, Inc. Led by Sabrina Martucci Johnson, public since 2014-04-10.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for DARE as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.